InvestorsHub Logo
icon url

falconer66a

02/18/23 4:34 PM

#403822 RE: Rubyred77 #403820

Watch. The FDA will get it "wrong."

No matter what news gets released, it will be met with the same ol characters attacking.


Well, those good folks are the real experts. They KNOW.

In fact, right after the FDA renders its first approval of blarcamesine for any one of the three indications currently on the table, we will be awed with their postings on how the FDA was "so wrong."

As readers here have already, we'll all need to learn from the naysaying experts who so effectively post here.
icon url

nidan7500

02/18/23 4:48 PM

#403823 RE: Rubyred77 #403820

Rubeyred77

News will happen when it happens.
We already know Parkinson’s p2 was a success, Rett adult p3 was a success, Alz p2b/3 was a success.



I also think the next big hit for AVXL will be the well written/compelling Peer reviewed doc which IMO, will put the AVXL MOA and TRIFECTA results at the top of the FDA list of , "Things to get DONE-ASAP."